<SEC-DOCUMENT>0001070081-21-000020.txt : 20210609
<SEC-HEADER>0001070081-21-000020.hdr.sgml : 20210609
<ACCEPTANCE-DATETIME>20210609160637
ACCESSION NUMBER:		0001070081-21-000020
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20210608
ITEM INFORMATION:		Material Modifications to Rights of Security Holders
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Submission of Matters to a Vote of Security Holders
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210609
DATE AS OF CHANGE:		20210609

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PTC THERAPEUTICS, INC.
		CENTRAL INDEX KEY:			0001070081
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				043416587
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35969
		FILM NUMBER:		211005206

	BUSINESS ADDRESS:	
		STREET 1:		100 CORPORATE COURT
		CITY:			SOUTH PLAINFIELD
		STATE:			NJ
		ZIP:			07080-2449
		BUSINESS PHONE:		9082227000

	MAIL ADDRESS:	
		STREET 1:		100 CORPORATE COURT
		CITY:			SOUTH PLAINFIELD
		STATE:			NJ
		ZIP:			07080-2449

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PTC THERAPEUTICS INC
		DATE OF NAME CHANGE:	19980909
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ptct-20210608x8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='UTF-8'?>

      <!-- iXBRL document created with: Toppan Merrill Bridge iXBRL 9.6.7713.40453 -->
      <!-- Based on: iXBRL 1.1 -->
      <!-- Created on: 6/9/2021 8:03:13 PM -->
      <!-- iXBRL Library version: 1.0.7713.40461 -->
      <!-- iXBRL Service Job ID: 0349e940-37ce-4625-bcaa-74fb1b45fd24 -->

  <html xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns="http://www.w3.org/1999/xhtml" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ptct="http://www.ptcbio.com/20210608" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrli="http://www.xbrl.org/2003/instance"><head><meta http-equiv="content-type" content="text/html" /><title></title></head><body><div style="margin-top:30pt;"></div><div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric contextRef="Duration_6_8_2021_To_6_8_2021_WGoHhJpxt0CIR5ZKZpm1Ow" name="dei:EntityCentralIndexKey" id="Tc_oifPGmChQEOsnea0KtYMjw_2_1">0001070081</ix:nonNumeric><ix:nonNumeric contextRef="Duration_6_8_2021_To_6_8_2021_WGoHhJpxt0CIR5ZKZpm1Ow" name="dei:AmendmentFlag" id="Tc_xsLViPQZh0mmuSFqXRU-VQ_3_1">false</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="ptct-20210608.xsd" xlink:type="simple"></link:schemaRef></ix:references><ix:resources><xbrli:context id="Duration_6_8_2021_To_6_8_2021_WGoHhJpxt0CIR5ZKZpm1Ow"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001070081</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-08</xbrli:startDate><xbrli:endDate>2021-06-08</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:1pt;padding-top:1pt;text-align:center;border-bottom:1.0pt solid #000000;border-top:3.0pt solid #000000;margin:0pt;"><span style="font-size:2pt;font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_1c2b8121_8120_4d2c_bf9a_3bd62a26e6df"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:17pt;font-weight:bold;">UNITED STATES</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:17pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">WASHINGTON, D.C. 20549</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:17pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">FORM&#160;</b><ix:nonNumeric contextRef="Duration_6_8_2021_To_6_8_2021_WGoHhJpxt0CIR5ZKZpm1Ow" name="dei:DocumentType" id="Narr_nsEAFxEYWUKmnRkLL7A4Ig"><b style="font-weight:bold;">8-K</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:11pt;font-weight:bold;">CURRENT REPORT</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:11pt;font-weight:bold;">Pursuant to Section&#160;13 or 15(d)&#160;of the Securities Exchange Act of 1934</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;white-space:pre-wrap;">Date of Report (Date of earliest event reported):  </span><ix:nonNumeric contextRef="Duration_6_8_2021_To_6_8_2021_WGoHhJpxt0CIR5ZKZpm1Ow" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="Narr_3vfTKxvI_0mc8vSAinrFFw"><b style="font-size:9pt;font-weight:bold;">June 8, 2021</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:17pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_6_8_2021_To_6_8_2021_WGoHhJpxt0CIR5ZKZpm1Ow" name="dei:EntityRegistrantName" id="Narr_VIZNz1m2z0S3gn8yp95D4w"><b style="font-weight:bold;">PTC THERAPEUTICS, INC.</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">(Exact Name of Company as Specified in Charter)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_55447ebd_8ac3_48f2_9214_a2803b87ebd3"></a><a id="Tc_l140KfAG1kuj-rnOUXNHZA_2_0"></a><a id="Tc_jLJ9r0feXEm75HoIoeUokQ_2_2"></a><a id="Tc_r2K_mtK1hUW9GeKZYIWvcQ_2_4"></a><a id="Tc_d6D8ZbnsO0qyK33RIOEcNw_3_0"></a><a id="Tc_UHWWe3Qfb0-JbKUmbiZIxQ_3_2"></a><a id="Tc_ENOyZdYaeEebfihNLMRz4w_3_4"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;table-layout:auto;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:31.75%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:2.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:31.76%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:2.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:31.76%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:31.75%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_6_8_2021_To_6_8_2021_WGoHhJpxt0CIR5ZKZpm1Ow" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="Tc_8qGrrFAcJ0KVeNrslwNraw_1_0"><b style="font-size:9pt;font-weight:bold;">Delaware</b></ix:nonNumeric></p></td><td style="vertical-align:bottom;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;width:31.76%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_6_8_2021_To_6_8_2021_WGoHhJpxt0CIR5ZKZpm1Ow" name="dei:EntityFileNumber" id="Tc__ixgryzHNUiyrISTmGWscg_1_2"><b style="font-size:9pt;font-weight:bold;">001-35969</b></ix:nonNumeric></p></td><td style="vertical-align:bottom;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;width:31.76%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_6_8_2021_To_6_8_2021_WGoHhJpxt0CIR5ZKZpm1Ow" name="dei:EntityTaxIdentificationNumber" id="Tc_1J1XBnmDE0ieSMOdEf1DeQ_1_4"><b style="font-size:9pt;font-weight:bold;">04-3416587</b></ix:nonNumeric></p></td></tr><tr><td style="vertical-align:bottom;width:31.75%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">(State or Other Jurisdiction</p></td><td style="vertical-align:bottom;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:31.76%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">(Commission</p></td><td style="vertical-align:bottom;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:31.76%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">(IRS Employer</p></td></tr><tr><td style="vertical-align:bottom;width:31.75%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">of Incorporation)</p></td><td style="vertical-align:bottom;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:31.76%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">File Number)</p></td><td style="vertical-align:bottom;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:31.76%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">Identification No.)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p><a id="_c0dd52bc_18a5_4ddb_b41a_c697e874a0ff"></a><a id="Tc__5ftKTPeO0ySj3Jx7se_cA_2_0"></a><a id="Tc_aSXit5WFxEmCdprOgRyVjg_3_0"></a><a id="Tc_q9f2m60m7kaXuSg4T8WihQ_3_2"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;table-layout:auto;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:48.53%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:2.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:48.52%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:48.53%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_6_8_2021_To_6_8_2021_WGoHhJpxt0CIR5ZKZpm1Ow" name="dei:EntityAddressAddressLine1" id="Tc_figXhwMNlEec9Jb20YtT9w_1_0"><b style="font-size:9pt;font-weight:bold;">100 Corporate Court</b></ix:nonNumeric></p></td><td style="vertical-align:bottom;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;width:48.52%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:48.53%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_6_8_2021_To_6_8_2021_WGoHhJpxt0CIR5ZKZpm1Ow" name="dei:EntityAddressCityOrTown" id="Narr_gdnIV0_-7kmPUfNty6EqVA"><b style="font-size:9pt;font-weight:bold;">South Plainfield</b></ix:nonNumeric><b style="font-size:9pt;font-weight:bold;">, </b><ix:nonNumeric contextRef="Duration_6_8_2021_To_6_8_2021_WGoHhJpxt0CIR5ZKZpm1Ow" name="dei:EntityAddressStateOrProvince" id="Narr_sbi59WIQTEyuYDq6Tvj-jg"><b style="font-size:9pt;font-weight:bold;">NJ</b></ix:nonNumeric></p></td><td style="vertical-align:bottom;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:48.52%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_6_8_2021_To_6_8_2021_WGoHhJpxt0CIR5ZKZpm1Ow" name="dei:EntityAddressPostalZipCode" id="Tc_YlnLupzWAEqG3GyxKM2D9A_2_2"><b style="font-size:9pt;font-weight:bold;">07080</b></ix:nonNumeric></p></td></tr><tr><td style="vertical-align:bottom;width:48.53%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">(Address of Principal Executive Offices)</p></td><td style="vertical-align:bottom;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:48.52%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">(Zip Code)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;">Registrant&#8217;s telephone number, including area code: </span><b style="font-size:9pt;font-weight:bold;">(</b><ix:nonNumeric contextRef="Duration_6_8_2021_To_6_8_2021_WGoHhJpxt0CIR5ZKZpm1Ow" name="dei:CityAreaCode" id="Narr_O9Vcg13dzkCVbPpM-rSgrA"><b style="font-size:9pt;font-weight:bold;">908</b></ix:nonNumeric><b style="font-size:9pt;font-weight:bold;">) </b><ix:nonNumeric contextRef="Duration_6_8_2021_To_6_8_2021_WGoHhJpxt0CIR5ZKZpm1Ow" name="dei:LocalPhoneNumber" id="Narr_JXy6NKRf1EqDdnNhtmPjVQ"><b style="font-size:9pt;font-weight:bold;">222-7000</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Not applicable</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">(Former Name or Former Address, if Changed Since Last Report)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-indent:36pt;margin:0pt;">Check the appropriate box below if the Form&#160;8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<i style="font-style:italic;">see</i> General Instruction A.2. below):</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:21.6pt;"><ix:nonNumeric contextRef="Duration_6_8_2021_To_6_8_2021_WGoHhJpxt0CIR5ZKZpm1Ow" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="Narr_efWfOrgumkOpujZZbD40Tw"><span style="color:#000000;font-family:'Segoe UI Symbol';font-size:9pt;font-style:normal;font-weight:normal;text-align:left;">&#9744;</span></ix:nonNumeric></span><span style="font-size:9pt;">Written communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:21.6pt;"><ix:nonNumeric contextRef="Duration_6_8_2021_To_6_8_2021_WGoHhJpxt0CIR5ZKZpm1Ow" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="Narr_TaqplGfcaU-sSsxwvEDe_Q"><span style="color:#000000;font-family:'Segoe UI Symbol';font-size:9pt;font-style:normal;font-weight:normal;text-align:left;">&#9744;</span></ix:nonNumeric></span><span style="font-size:9pt;">Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:21.6pt;"><ix:nonNumeric contextRef="Duration_6_8_2021_To_6_8_2021_WGoHhJpxt0CIR5ZKZpm1Ow" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="Narr_jy6eWaNIm0Cxp9u6g9LEWQ"><span style="color:#000000;font-family:'Segoe UI Symbol';font-size:9pt;font-style:normal;font-weight:normal;text-align:left;">&#9744;</span></ix:nonNumeric></span><span style="font-size:9pt;">Pre-commencement communications pursuant to Rule&#160;14d-2(b)&#160;under the Exchange Act (17 CFR 240.14d-2(b))</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:21.6pt;"><ix:nonNumeric contextRef="Duration_6_8_2021_To_6_8_2021_WGoHhJpxt0CIR5ZKZpm1Ow" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="Narr_nWubzcjC-UiifRhBWY-98w"><span style="color:#000000;font-family:'Segoe UI Symbol';font-size:9pt;font-style:normal;font-weight:normal;text-align:left;">&#9744;</span></ix:nonNumeric></span><span style="font-size:9pt;">Pre-commencement communications pursuant to Rule&#160;13e-4(c)&#160;under the Exchange Act (17 CFR 240.13e-4(c))</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Securities registered pursuant to Section&#160;12(b)&#160;of the Act:</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_78f9e492_9551_4dcc_bd52_e93e8cab4c26"></a><a id="Tc_rW1tYsM5ckmC52knTxDMcw_1_0"></a><a id="Tc_XSjBYVOlTE-9GESxwri0vg_1_2"></a><a id="Tc_9kE2_4Lts0GyE1ZUCBHlUw_1_4"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:37.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:19.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:37.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:37.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Title of each class</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:19.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Trading Symbol(s)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:37.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Name of each exchange on which registered</b></p></td></tr><tr><td style="vertical-align:bottom;width:37.99%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:-7.2pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_6_8_2021_To_6_8_2021_WGoHhJpxt0CIR5ZKZpm1Ow" name="dei:Security12bTitle" id="Tc_86ePEMLuAEuH-yoTf2gJhw_2_0"><span style="font-size:9pt;">Common Stock, $0.001 par value per share</span></ix:nonNumeric></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:19.99%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_6_8_2021_To_6_8_2021_WGoHhJpxt0CIR5ZKZpm1Ow" name="dei:TradingSymbol" id="Tc_KDYc_RCKLUiyoi_N8uQqyg_2_2"><span style="font-size:9pt;">PTCT</span></ix:nonNumeric></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:37.84%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_6_8_2021_To_6_8_2021_WGoHhJpxt0CIR5ZKZpm1Ow" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="Tc_8fQjhQcGhkuzdZs9hSiCVA_2_4"><span style="font-size:9pt;">Nasdaq Global Select Market</span></ix:nonNumeric></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule&#160;405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule&#160;12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;">Emerging growth company </span><ix:nonNumeric contextRef="Duration_6_8_2021_To_6_8_2021_WGoHhJpxt0CIR5ZKZpm1Ow" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="Narr_h2cFllPupUip7JeLmcr54w"><span style="font-family:'Segoe UI Symbol';font-size:9pt;">&#9744;</span></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a)&#160;of the Exchange Act. <span style="font-family:'Segoe UI Symbol';">&#9744;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:1pt;padding-top:1pt;border-bottom:3.0pt solid #000000;border-top:1.0pt solid #000000;margin:0pt;"><span style="font-size:2pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt;"><span style="font-size:0pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_8de62413_916b_4c21_8535_21832bd9c22a"></a><p style="background-color:#ffffff;font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;margin:0pt;"><b style="font-weight:bold;">Item 3.03. Material Modification to Rights of Security Holders.</b></p><p style="background-color:#ffffff;font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;margin:0pt;">PTC Therapeutics, Inc. (the &#8220;Company&#8221;) held its Annual Meeting on June 8, 2021 (the &#8220;Annual Meeting&#8221;). At the Annual Meeting, the stockholders of the Company approved an amendment to the Company&#8217;s Restated Certificate of Incorporation (the &#8220;Restated Certificate&#8221;), to increase the number of authorized shares of common stock of the Company from 125,000,000 to 250,000,000. On June 9, 2021, the Company filed a certificate of amendment to the Restated Certificate (the &#8220;Certificate of Amendment&#8221;) with the Delaware Secretary of State, giving effect to the authorized share increase. The foregoing summary of the Certificate of Amendment is qualified in its entirety by reference to the full text of the Certificate of Amendment, which is attached as Exhibit 3.1 hereto and is incorporated herein by reference.</p><a id="_e91e6d67_1879_459f_b93d_e7469c1f2937"></a><p style="background-color:#ffffff;font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;margin:0pt;"><b style="font-weight:bold;">Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</b></p><p style="background-color:#ffffff;font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;margin:0pt;">At the Annual Meeting, the stockholders of the Company approved an amendment to the Company&#8217;s 2016 Employee Stock Purchase Plan (the &#8220;Plan&#8221;) to increase the number of shares of common stock authorized for issuance under the Plan from 1,000,000 to 2,000,000 (the Plan as so amended, the &#8220;Amended Plan&#8221;). The only difference between the terms of the Plan and the Amended Plan is that the Amended Plan provides that an additional 1,000,000 shares of the Company&#8217;s common stock may be issued pursuant to the Amended Plan. The foregoing summary of the Amended Plan is qualified in its entirety by reference to the full text of the Amended Plan, which is attached as Exhibit 10.1 hereto and is incorporated herein by reference.</p><a id="_0005bee0_2063_49b7_b5e6_ffad2cbfbe2d"></a><p style="background-color:#ffffff;font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;margin:0pt;"><b style="font-weight:bold;">Item&#160;5.07. Submission of Matters to a Vote of Security Holders.</b></p><p style="background-color:#ffffff;font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="white-space:pre-wrap;">The final results for the votes regarding each proposal at the Annual Meeting are set forth below.  As of the record date of the Annual Meeting, April 16, 2021, there were 70,418,067 shares of the Company&#8217;s common stock outstanding. Each share of common stock entitled its holder to one vote per share.</span></p><p style="background-color:#ffffff;font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="background-color:#ffffff;font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The stockholders of the Company elected four Class II directors, each to hold office until the Company&#8217;s 2024 annual meeting of stockholders or until his or her successor has been duly elected and qualified, as follows:</p><p style="background-color:#ffffff;font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:99.89%;"><tr style="height:1pt;"><td style="vertical-align:top;width:30.64%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:22.27%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:22.1%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:24.97%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:top;width:30.64%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Director</b></p></td><td style="vertical-align:top;width:22.27%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">For</b></p></td><td style="vertical-align:top;width:22.1%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">Withheld</b></p></td><td style="vertical-align:top;width:24.97%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">Broker Non-Votes</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:top;width:30.64%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Emma Reeve</p></td><td style="background-color:#cceeff;vertical-align:top;width:22.27%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">63,957,342</p></td><td style="background-color:#cceeff;vertical-align:top;width:22.1%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">149,380</p></td><td style="background-color:#cceeff;vertical-align:top;width:24.97%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">2,228,392</p></td></tr><tr><td style="vertical-align:top;width:30.64%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Michael Schmertzler</p></td><td style="vertical-align:top;width:22.27%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">63,052,545</p></td><td style="vertical-align:top;width:22.1%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">1,054,177</p></td><td style="vertical-align:top;width:24.97%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">2,228,392</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:top;width:30.64%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Glenn D. Steele Jr., M.D., Ph.D.</p></td><td style="background-color:#cceeff;vertical-align:top;width:22.27%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">63,855,911</p></td><td style="background-color:#cceeff;vertical-align:top;width:22.1%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">250,811</p></td><td style="background-color:#cceeff;vertical-align:top;width:24.97%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">2,228,392</p></td></tr><tr><td style="vertical-align:top;width:30.64%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Mary Smith</p></td><td style="vertical-align:top;width:22.27%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">64,002,465</p></td><td style="vertical-align:top;width:22.1%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">104,257</p></td><td style="vertical-align:top;width:24.97%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">2,228,392</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="background-color:#ffffff;font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">An amendment to the Restated Certificate to increase the number of authorized shares of common stock from 125,000,000 to 250,000,000 was approved by the Company&#8217;s stockholders with 65,318,627 votes &#8220;For,&#8221; 1,007,562 votes &#8220;Against,&#8221; and 8,925 votes &#8220;Abstained.&#8221;</p><p style="background-color:#ffffff;font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="background-color:#ffffff;font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">An amendment to the Plan to increase the number of shares of common stock authorized for issuance under the Plan from 1,000,000 to 2,000,000 was approved by the Company&#8217;s stockholders with 63,819,077 votes &#8220;For,&#8221; 276,838 votes &#8220;Against,&#8221; 10,807 votes &#8220;Abstained,&#8221; and 2,228,392 broker non-votes.</p><p style="background-color:#ffffff;font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="background-color:#ffffff;font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The appointment of Ernst &amp; Young LLP as the Company&#8217;s independent registered public accounting firm for the fiscal year ending December 31, 2021 was ratified by the Company&#8217;s stockholders with 66,168,440 votes &#8220;For,&#8221; 127,352 votes &#8220;Against,&#8221; and 39,322 votes &#8220;Abstained.&#8221;</p><p style="background-color:#ffffff;font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="background-color:#ffffff;font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The non-binding advisory proposal on named executive officer compensation was approved by the Company&#8217;s stockholders with 62,819,789 votes &#8220;For,&#8221; 1,238,777 votes &#8220;Against,&#8221; 48,156 votes &#8220;Abstained,&#8221; and 2,228,392 broker non-votes.</p><p style="background-color:#ffffff;font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_00c374eb_0118_4061_8a8d_70ded480bd97"></a></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Item&#160;9.01.&#160;Financial Statements and Exhibits.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">(d)&#160;Exhibits</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;table-layout:auto;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:15%;margin:0pt;padding:0pt 2pt 0pt 0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:82.93%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 2pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Exhibit&#160;No.</b></p></td><td style="vertical-align:bottom;width:2.06%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;width:82.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Description</b></p></td></tr><tr><td style="vertical-align:bottom;width:15%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">3.1</p></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:82.93%;margin:0pt;padding:0pt 2pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;" href="ptct-20210608ex31f4f15c6.htm"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Certificate of Amendment to the Restated Certificate of Incorporation of PTC Therapeutics, Inc.</span></a></p></td></tr><tr><td style="vertical-align:bottom;width:15%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">10.1</p></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:82.93%;margin:0pt;padding:0pt 2pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;" href="ptct-20210608ex10141119a.htm"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">PTC Therapeutics, Inc. Amended and Restated 2016 Employee Stock Purchase Plan</span></a></p></td></tr><tr><td style="vertical-align:bottom;width:15%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">104</p></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:82.93%;margin:0pt;padding:0pt 2pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The cover page&#160;from this Current Report on Form&#160;8-K, formatted in Inline XBRL</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_63e2b05b_6c05_4329_ae5b_8f5aebdbaf1a"></a></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Signature</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;table-layout:auto;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:49.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:5.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:44.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:49.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:50.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">PTC Therapeutics,&#160;Inc.</b></p></td></tr><tr><td style="vertical-align:bottom;width:49.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:50.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:49.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Date: June 9, 2021</p></td><td style="vertical-align:bottom;width:5.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By:</p></td><td style="vertical-align:bottom;width:44.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">/s/ Mark Boulding</p></td></tr><tr><td style="vertical-align:bottom;width:49.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Name:</p></td><td style="vertical-align:bottom;width:44.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Mark Boulding</p></td></tr><tr><td style="vertical-align:bottom;width:49.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Title:</p></td><td style="vertical-align:bottom;width:44.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Executive Vice President and Chief Legal Officer</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:avoid;width:79.3%;border:0;"></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>ptct-20210608ex31f4f15c6.htm
<DESCRIPTION>EX-3.1
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  9.10.0.88--><!--Created on: 6/9/2021 08:02:53 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:right;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">EXHIBIT 3.1</b></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:center;margin:12pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">CERTIFICATE OF AMENDMENT </font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">TO THE RESTATED CERTIFICATE OF INCORPORATION OF </font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">PTC THERAPEUTICS, INC.</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">PTC Therapeutics, Inc. (the &#8220;Corporation&#8221;), a corporation organized and existing under and by virtue of the provisions of the General Corporation Law of the State of Delaware, does hereby certify as follows:</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="color:#000000;font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;line-height:1.19;text-align:left;">A.</font></font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;white-space:pre-wrap;">The current name of the Corporation is PTC Therapeutics, Inc.  The original Certificate of Incorporation was filed with the Secretary of State of the State of Delaware on March 31, 1998.  The Certificate of Incorporation was most recently amended and restated on June 25, 2013.</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="color:#000000;font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;line-height:1.19;text-align:left;">B.</font></font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">The first paragraph of Article FOURTH of the Certificate of Incorporation is hereby amended in its entirety to read as follows:</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt 36pt 0pt 36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">&#8220;FOURTH: The total number of shares of all classes of stock which the Corporation shall have authority to issue is Two Hundred Fifty-Five Million (255,000,000) shares, consisting of (i) Two Hundred Fifty Million (250,000,000) shares of Common Stock, $0.001 par value per share (&#8220;Common Stock&#8221;), and (ii) Five Million (5,000,000) shares of Preferred Stock, $0.001 par value per share (&#8220;Preferred Stock&#8221;).&#8221;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt 36pt 0pt 36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin-left:0pt;margin-right:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="color:#000000;font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;line-height:1.19;text-align:left;">C.</font></font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">That, pursuant to resolution of the Corporation&#8217;s board of directors, a meeting of the stockholders of the Corporation was duly called and held upon notice in accordance with Section 222 of the DGCL, at which meeting the necessary number of shares as required by statute were voted in favor of this Certificate of Amendment.</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="color:#000000;font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;line-height:1.19;text-align:left;">D.</font></font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">This Certificate of Amendment was duly adopted by the directors and stockholders of the Corporation in accordance with the provisions of Section 242 of the DGCL.</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">IN WITNESS WHEREOF, the Corporation has caused this Certificate of Amendment to the Certificate of Incorporation to be signed by the authorized officer below as of this 9</font><sup style="font-family:'Times New Roman','Times','serif';font-size:9pt;vertical-align:top;">th</sup><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;"> day of June, 2021.</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">By:</font><u style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-decoration:underline;text-decoration-color:#000000;">/s/ Mark E. Boulding</u><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">_________________________</font><font style="display:inline-block;width:19.33pt;"></font><font style="display:inline-block;width:36pt;"></font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">Name: Mark E. Boulding</font><font style="display:inline-block;width:22.02pt;"></font><font style="display:inline-block;width:36pt;"></font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">Title: Executive Vice President and Chief Legal Officer</font><font style="display:inline-block;width:19.78pt;"></font><font style="display:inline-block;width:36pt;"></font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:avoid;width:76.47%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>3
<FILENAME>ptct-20210608ex10141119a.htm
<DESCRIPTION>EX-10.1
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  9.10.0.88--><!--Created on: 6/9/2021 08:03:05 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:right;margin:0pt;"><b style="font-weight:bold;">EXHIBIT 10.1</b></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:center;margin:12pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">PTC THERAPEUTICS,&#160;INC.<br>AMENDED AND RESTATED 2016 EMPLOYEE STOCK PURCHASE PLAN</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:12pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The purpose of this Amended and Restated 2016 Employee Stock Purchase Plan (this &quot;Plan&quot;) is to provide eligible employees of PTC Therapeutics,&#160;Inc. (the &quot;Company&quot;) and certain of its subsidiaries with opportunities to purchase shares of the Company&#39;s common stock, $0.001 par value per share (the &quot;Common Stock&quot;). Subject to adjustment under Section&#160;15 hereof, the number of shares of Common Stock that have been approved for this purpose is up to 2,000,000 shares of Common Stock. </font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:12pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;This Plan is intended to qualify as an &quot;employee stock purchase plan&quot; as defined in Section&#160;423 of the Internal Revenue Code of 1986, as amended (the &quot;Code&quot;), and the regulations issued thereunder, and shall be interpreted consistent therewith. </font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:12pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1.</font><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;">&#160;&#160;&#160;&#160;Administration</i><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">.&#160;&#160;&#160;&#160;The Plan will be administered by the Board of Directors of the Company (the &quot;Board&quot;) or by a committee appointed by the Board (the &quot;Committee&quot;). The Board or the Committee has authority to make rules and regulations for the administration of the Plan and its interpretation and decisions with regard thereto shall be final and conclusive. The Board or the Committee may delegate to one or more officers of the Company the authority to implement and administer the Plan (such officer or officers, the &quot;Administrator&quot;), subject to the terms of this Plan and any implementation guidelines approved by the Board or the Committee (the &quot;Plan Guidelines&quot;). </font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:12pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2.</font><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;">&#160;&#160;&#160;&#160;Eligibility</i><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">.&#160;&#160;&#160;&#160;Except as provided in the Plan Guidelines or an International Sub-Plan (as defined below), all employees of the Company and all employees of any subsidiary of the Company (as defined in Section&#160;424(f) of the Code) designated by the Board or the Committee from time to time (a &quot;Designated Subsidiary&quot;), are eligible to participate in any one or more of the offerings of Options (as defined in Section&#160;9) to purchase Common Stock under the Plan provided that: </font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:12pt 0pt 12pt 36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(a)&#160;&#160;&#160;they are customarily employed by the Company or a Designated Subsidiary for more than twenty (20)&#160;hours a week (or such lesser number of hours as may be provided in the Plan Guidelines) and for more than five (5)&#160;months in a calendar year (or such lesser number of months as may be provided in the Plan Guidelines); </font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:12pt 0pt 12pt 36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(b)&#160;&#160;&#160;they have been employed by the Company or a Designated Subsidiary for two years or more (or such shorter period of time as may be provided in the Plan Guidelines) prior to enrolling in the Plan; and </font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:12pt 0pt 12pt 36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(c)&#160;&#160;&#160;they are employees of the Company or a Designated Subsidiary on the first day of the applicable Plan Period (as defined below). </font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:12pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">No employee may be granted an Option hereunder if such employee, immediately after the Option is granted, owns 5% or more of the total combined voting power or value of the stock of the Company or any subsidiary of the Company. For purposes of the preceding sentence, the attribution rules of Section&#160;424(d) of the Code shall apply in determining the stock ownership of </font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">an employee, and all stock that the employee has a contractual right to purchase shall be treated as stock owned by the employee. </font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:12pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company retains the discretion to determine which eligible employees may participate in an offering pursuant to and consistent with Treasury Regulation Sections&#160;1.423-2(e) and (f). </font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:12pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;3.</font><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;">&#160;&#160;&#160;&#160;Offerings</i><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">.&#160;&#160;&#160;&#160;The Company will make one or more offerings (&quot;Offerings&quot;) to employees to purchase stock under this Plan. Offerings will begin on the date or dates provided in the Plan Guidelines (such dates, the &quot;Offering Commencement Dates&quot;). Each Offering Commencement Date will begin a period of six months, or such other period as is provided in the Plan Guidelines (such period, a &quot;Plan Period&quot;), during which payroll deductions will be made and held for the purchase of Common Stock at the end of the Plan Period. The Board or the Committee may, at its discretion, choose a different Plan Period of not more than twenty seven (27)&#160;months for Offerings, as provided in the Plan Guidelines. </font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:12pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;4.</font><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;">&#160;&#160;&#160;&#160;Participation</i><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">.&#160;&#160;&#160;&#160;An employee eligible on the Offering Commencement Date of any Offering may participate in such Offering by completing and forwarding either a written or electronic payroll deduction authorization form to the employee&#39;s appropriate payroll office at the time provided in the Plan Guidelines. The form will authorize a regular payroll deduction from the Compensation received by the employee during the Plan Period. Unless an employee files&#160;a new form during the enrollment period or withdraws from the Plan in the manner set forth in the Plan and the Plan Guidelines, his or her deductions and purchases will continue at the same rate for future Offerings under the Plan as long as the Plan remains in effect. The term &quot;Compensation&quot; means the amount of money reportable on the employee&#39;s Federal Income Tax Withholding Statement, excluding overtime, shift premium, incentive or bonus awards, all allowances including but not limited to benefit, automobile and meal allowances, reimbursements for expenses such as relocation allowances for travel expenses, income or gains associated with the grant or vesting of restricted stock, income or gains on the exercise of Company stock options or stock appreciation rights, and similar items, whether or not shown or separately identified on the employee&#39;s Federal Income Tax Withholding Statement, but including, in the case of salespersons, sales commissions, as provided in the Plan Guidelines. </font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:12pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;5.</font><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;">&#160;&#160;&#160;&#160;Deductions</i><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">.&#160;&#160;&#160;&#160;The Company will maintain payroll deduction accounts for all participating employees. With respect to any Offering made under this Plan, an employee may authorize a payroll deduction in any percentage amount (in whole percentages) of the Compensation he or she receives during the Plan Period or such shorter period during which deductions from payroll are made, with the maximum such percentage amount provided in the Plan Guidelines. The minimum payroll deduction is such percentage of Compensation as may be established from time to time by the Board or the Committee, as provided in the Plan Guidelines. </font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:12pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;6.</font><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;">&#160;&#160;&#160;&#160;Deduction Changes</i><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">.&#160;&#160;&#160;&#160;An employee may not increase or decrease his or her payroll deduction during any Plan Period, except to the extent provided in the Plan Guidelines. </font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:12pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;7.</font><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;">&#160;&#160;&#160;&#160;Interest</i><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">.&#160;&#160;&#160;&#160;Interest will not be paid on any employee accounts, except to the extent that the Board or the Committee may otherwise provide in the Plan Guidelines. </font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;8.</font><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;">&#160;&#160;&#160;&#160;Withdrawal of Funds</i><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">.&#160;&#160;&#160;&#160;An employee may prior to the end of a Plan Period, but within the time period provided in the Plan Guidelines, and for any reason permanently draw out the balance accumulated in the employee&#39;s account and thereby withdraw from participation in an Offering. Partial withdrawals are not permitted, except as otherwise determined by the Board or the Committee and provided in the Plan Guidelines. The employee may not begin participation again during the remainder of the Plan Period during which the employee withdrew his or her balance. The employee may participate in any subsequent Offering in accordance with terms and conditions established by the Board or the Committee, or as provided in the Plan Guidelines. </font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:12pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;9.</font><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;">&#160;&#160;&#160;&#160;Purchase of Shares</i><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">.&#160;&#160;&#160;&#160;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:12pt 0pt 12pt 36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(a)</font><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;">&#160;&#160;&#160;&#160;Number of Shares</i><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">.&#160;&#160;&#160;&#160;On the Offering Commencement Date, the Company will grant to each eligible employee who is then a participant in the Plan an option (an &quot;Option&quot;) to purchase on the last business day of such Plan Period (the &quot;Exercise Date&quot;) at the applicable purchase price (the &quot;Option Price&quot;) up to that number of shares of Common Stock determined by multiplying $2,083 by the number of full months in the Plan Period and dividing the result by the Closing Price (as defined below) on the Offering Commencement Date; provided, however, that no employee may be granted an Option which permits his or her rights to purchase Common Stock under this Plan and any other employee stock purchase plan (as defined in Section&#160;423(b) of the Code) of the Company and its subsidiaries, to accrue at a rate which exceeds $25,000 of the fair market value of such Common Stock (determined at the date such Option is granted) for each calendar year in which the Option is outstanding at any time; and, provided, further, however, that the Committee may, to the extent provided in the Plan Guidelines, establish a fixed maximum number of shares of Common Stock that each eligible employee may purchase per Plan Period which number may not be greater than the number of shares of Common Stock determined by using the formula in the first clause of this Section&#160;9(a) and which number shall be subject to the second clause of this Section&#160;9(a)(such limit, the &quot;Share Limit&quot;). </font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:12pt 0pt 12pt 36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(b)</font><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;">&#160;&#160;&#160;&#160;Option Price</i><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">.&#160;&#160;&#160;&#160;The Board or the Committee shall determine and provide in the Plan Guidelines the Option Price for each Plan Period, including whether such Option Price shall be determined based on the lesser of the Closing Price of the Common Stock on (i)&#160;the Offering Commencement Date or (ii)&#160;the Exercise Date, or shall be based solely on the Closing Price of the Common Stock on the Exercise Date; provided, however, that such Option Price shall be at least 85% of the applicable Closing Price. The &quot;Closing Price&quot; shall be (a)&#160;the closing price (for the primary trading session) on any national securities exchange on which the Common Stock is listed or (b)&#160;the average of the closing bid and asked prices in the over-the-counter-market, whichever is applicable, as published in The Wall Street Journal or another source selected by the Board or the Committee or as provided in the Plan Guidelines. If no sales of Common Stock were made on such a day, the price of the Common Stock shall be the reported price for the next preceding day on which sales were made. </font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:12pt 0pt 0pt 36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(c)</font><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;">&#160;&#160;&#160;&#160;Exercise of Option</i><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">.&#160;&#160;&#160;&#160;Each employee who continues to be a participant in the Plan on the Exercise Date shall be deemed to have exercised his or her Option at the Option Price on such date and shall be deemed to have purchased from the Company the </font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">number of whole shares of Common Stock reserved for the purpose of the Plan that his or her accumulated payroll deductions on such date will pay for, but not in excess of the maximum numbers determined in the manner set forth above. </font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:12pt 0pt 12pt 36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(d)</font><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;">&#160;&#160;&#160;&#160;Return of Unused Payroll Deductions</i><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">.&#160;&#160;&#160;&#160;Any balance remaining in an employee&#39;s payroll deduction account at the end of a Plan Period will be automatically refunded to the employee, except that any balance that is less than the purchase price of one share of Common Stock will be carried forward into the employee&#39;s payroll deduction account for the following Offering, unless the employee elects not to participate in the following Offering under the Plan, in which case the balance in the employee&#39;s account shall be refunded. </font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:12pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;10.</font><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;">&#160;&#160;&#160;&#160;Issuance of Common Stock upon Exercise</i><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">.&#160;&#160;&#160;&#160;The Company shall provide for the delivery of the shares of Common Stock purchased at the end of a Plan Period in such manner as is provided in the Plan Guidelines, which may, for the avoidance of doubt, be in book entry. The shares of Common Stock purchased under the Plan may be issued only in the name of the employee, in the name of the employee and another person of legal age as joint tenants with rights of survivorship, or (in the Company&#39;s sole discretion) in the name of a brokerage firm, bank, or other nominee holder designated by the employee. </font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:12pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;11.</font><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;">&#160;&#160;&#160;&#160;Rights on Retirement, Death or Termination of Employment</i><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">.&#160;&#160;&#160;&#160;If a participating employee&#39;s employment ends before the last business day of a Plan Period, no payroll deduction shall be taken from any pay then due and owing to the employee and the balance in the employee&#39;s account shall be paid to the employee. In the event of the employee&#39;s death before the last business day of a Plan Period, the Company shall, upon notification of such death, pay the balance of the employee&#39;s account (a)&#160;to the executor or administrator of the employee&#39;s estate or (b)&#160;if no such executor or administrator has been appointed to the knowledge of the Company, to such other person(s) as the Company may, in its discretion, designate. If, before the last business day of the Plan Period, the Designated Subsidiary by which an employee is employed ceases to be a subsidiary of the Company, or if the employee is transferred to a subsidiary of the Company that is not a Designated Subsidiary, the employee shall be deemed to have terminated employment for the purposes of this Plan. </font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:12pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;12.</font><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;">&#160;&#160;&#160;&#160;Optionees Not Stockholders</i><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">.&#160;&#160;&#160;&#160;Neither the granting of an Option to an employee nor the deductions from his or her pay shall make such employee a stockholder of the shares of Common Stock covered by an Option under this Plan until he or she has purchased and received such shares. </font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:12pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;13.</font><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;">&#160;&#160;&#160;&#160;Options Not Transferable</i><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">.&#160;&#160;&#160;&#160;Options under this Plan are not transferable by a participating employee other than by will or the laws of descent and distribution, and are exercisable during the employee&#39;s lifetime only by the employee. </font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:12pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;14.</font><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;">&#160;&#160;&#160;&#160;Application of Funds</i><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">.&#160;&#160;&#160;&#160;All funds received or held by the Company under this Plan may be combined with other corporate funds and may be used for any corporate purpose. </font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:12pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;15.</font><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;">&#160;&#160;&#160;&#160;Adjustment for Changes in Common Stock and Certain Other Events</i><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">.&#160;&#160;&#160;&#160;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(a)</font><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;">&#160;&#160;&#160;&#160;Changes in Capitalization</i><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">.&#160;&#160;&#160;&#160;In the event of any stock split, reverse stock split, stock dividend, recapitalization, combination of shares, reclassification of shares, spin-off or other similar change in capitalization or event, or any dividend or distribution to holders of Common Stock other than an ordinary cash dividend, (i)&#160;the number and class of securities available under this Plan, (ii)&#160;the share limitations set forth in Section&#160;9, and (iii)&#160;the Option Price shall be equitably adjusted to the extent determined by the Board or the Committee. </font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:12pt 0pt 12pt 36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(b)</font><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;">&#160;&#160;&#160;&#160;Reorganization Events</i><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">.&#160;&#160;&#160;&#160;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:12pt 0pt 12pt 72pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(1)</font><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;">&#160;&#160;&#160;&#160;Definition</i><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">.&#160;&#160;&#160;&#160;A &quot;Reorganization Event&quot; shall mean: (a)&#160;any merger or consolidation of the Company with or into another entity as a result of which all of the Common Stock of the Company is converted into or exchanged for the right to receive cash, securities or other property or is cancelled, (b)&#160;any transfer or disposition of all of the Common Stock of the Company for cash, securities or other property pursuant to a share exchange or other transaction or (c)&#160;any liquidation or dissolution of the Company. </font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:12pt 0pt 0pt 72pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(2)</font><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;">&#160;&#160;&#160;&#160;Consequences of a Reorganization Event on Options</i><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">.&#160;&#160;&#160;&#160;In connection with a Reorganization Event, the Board or the Committee may take any one or more of the following actions as to outstanding Options on such terms as the Board or the Committee determines: (i)&#160;provide that Options shall be assumed, or substantially equivalent Options shall be substituted, by the acquiring or succeeding corporation (or an affiliate thereof), (ii)&#160;upon written notice to employees, provide that all outstanding Options will be terminated immediately prior to the consummation of such Reorganization Event and that all such outstanding Options will become exercisable to the extent of accumulated payroll deductions as of a date specified by the Board or the Committee in such notice, which date shall not be less than ten (10)&#160;days preceding the effective date of the Reorganization Event, (iii)&#160;upon written notice to employees, provide that all outstanding Options will be cancelled as of a date prior to the effective date of the Reorganization Event and that all accumulated payroll deductions will be returned to participating employees on such date, (iv)&#160;in the event of a Reorganization Event under the terms of which holders of Common Stock will receive upon consummation thereof a cash payment for each share surrendered in the Reorganization Event (the &quot;Acquisition Price&quot;), change the last day of the Plan Period to be the date of the consummation of the Reorganization Event and make or provide for a cash payment to each employee equal to (A)&#160;(1) the Acquisition Price times (2)&#160;the number of shares of Common Stock that the employee&#39;s accumulated payroll deductions as of immediately prior to the Reorganization Event could purchase at the Option Price, where the Acquisition Price is treated as the fair market value of the Common Stock on the last day of the applicable Plan Period for purposes of determining the Option Price under Section&#160;9(b) hereof, and where the number of shares that could be purchased is subject to the limitations set forth in Section&#160;9(a), minus (B)&#160;the result of multiplying such number of shares by such Option Price, (v)&#160;provide that, in connection with a liquidation or dissolution of the Company, Options shall convert into the right to </font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 72pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">receive liquidation proceeds (net of the Option Price thereof) and (vi)&#160;any combination of the foregoing. </font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:12pt 0pt 12pt 72pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;For purposes of clause&#160;(i) above, an Option shall be considered assumed if, following consummation of the Reorganization Event, the Option confers the right to purchase, for each share of Common Stock subject to the Option immediately prior to the consummation of the Reorganization Event, the consideration (whether cash, securities or other property) received as a result of the Reorganization Event by holders of Common Stock for each share of Common Stock held immediately prior to the consummation of the Reorganization Event (and if holders were offered a choice of consideration, the type of consideration chosen by the holders of a majority of the outstanding shares of Common Stock); provided, however, that if the consideration received as a result of the Reorganization Event is not solely common stock of the acquiring or succeeding corporation (or an affiliate thereof), the Company may, with the consent of the acquiring or succeeding corporation, provide for the consideration to be received upon the exercise of Options to consist solely of such number of shares of common stock of the acquiring or succeeding corporation (or an affiliate thereof) that the Board determines to be equivalent in value (as of the date of such determination or another date specified by the Board) to the per share consideration received by holders of outstanding shares of Common Stock as a result of the Reorganization Event. </font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:12pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;16.</font><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;">&#160;&#160;&#160;&#160;Amendment of the Plan</i><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">.&#160;&#160;&#160;&#160;The Board may at any time, and from time to time, amend or suspend this Plan or any portion thereof, except that (a)&#160;if the approval of any such amendment by the shareholders of the Company is required by Section&#160;423 of the Code, such amendment shall not be effected without such approval, and (b)&#160;in no event may any amendment be made that would cause the Plan to fail to comply with Section&#160;423 of the Code. </font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:12pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;17.</font><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;">&#160;&#160;&#160;&#160;Insufficient Shares</i><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">.&#160;&#160;&#160;&#160;If the total number of shares of Common Stock specified in elections to be purchased under any Offering plus the number of shares purchased under previous Offerings under this Plan exceeds the maximum number of shares issuable under this Plan, the Board or the Committee will allot the shares then available on a pro-rata basis. </font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:12pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;18.</font><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;">&#160;&#160;&#160;&#160;Termination of the Plan</i><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">.&#160;&#160;&#160;&#160;This Plan may be terminated at any time by the Board. Upon termination of this Plan all amounts in the accounts of participating employees shall be promptly refunded. </font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:12pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;19.</font><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;">&#160;&#160;&#160;&#160;Governmental Regulations</i><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">.&#160;&#160;&#160;&#160;The Company&#39;s obligation to sell and deliver Common Stock under this Plan is subject to listing on a national stock exchange (to the extent the Common Stock is then so listed or quoted) and the approval of all governmental authorities required in connection with the authorization, issuance or sale of such stock. </font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:12pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;20.</font><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;">&#160;&#160;&#160;&#160;Governing Law</i><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">.&#160;&#160;&#160;&#160;The Plan shall be governed by Delaware law except to the extent that such law is preempted by federal law. </font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;21.</font><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;">&#160;&#160;&#160;&#160;Issuance of Shares</i><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">.&#160;&#160;&#160;&#160;Shares may be issued upon exercise of an Option from authorized but unissued Common Stock, from shares held in the treasury of the Company, or from any other proper source. </font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:12pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;22.</font><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;">&#160;&#160;&#160;&#160;Notification upon Sale of Shares</i><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">.&#160;&#160;&#160;&#160;Each employee agrees, by entering the Plan, to promptly give the Company notice of any disposition of shares purchased under the Plan where such disposition occurs within two years after the date of grant of the Option pursuant to which such shares were purchased. </font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:12pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;23.</font><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;">&#160;&#160;&#160;&#160;Grants to Employees in Foreign Jurisdictions</i><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">.&#160;&#160;&#160;&#160;The Company may, to comply with the laws of a foreign jurisdiction, grant Options to employees of the Company or a Designated Subsidiary who are citizens or residents of such foreign jurisdiction (without regard to whether they are also citizens of the United States or resident aliens (within the meaning of Section&#160;7701(b)(1)(A) of the Code)) with terms that are less favorable (but not more favorable) than the terms of Options granted under the Plan to employees of the Company or a Designated Subsidiary who are resident in the United States; provided, however, that the Board or the Committee may adopt a sub-plan with one or more appendices including specific Offering terms applicable to specific non-U.S. Designated Subsidiaries which Offering terms need not be less favorable, but must in all cases comply with Section&#160;423 of the Code (such sub-plan, an &quot;International Sub-plan&quot;). Notwithstanding the preceding provisions of this Plan, employees of the Company or a Designated Subsidiary who are citizens or residents of a foreign jurisdiction (without regard to whether they are also citizens of the United States or resident aliens (within the meaning of Section&#160;7701(b)(1)(A) of the Code)) may be excluded from eligibility under the Plan if (a)&#160;the grant of an Option under the Plan to a citizen or resident of the foreign jurisdiction is prohibited under the laws of such jurisdiction or (b)&#160;compliance with the laws of the foreign jurisdiction would cause the Plan to violate the requirements of Section&#160;423 of the Code. </font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:12pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;24.</font><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;">&#160;&#160;&#160;&#160;Authorization of Sub-Plans</i><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">.&#160;&#160;&#160;&#160;The Board or the Committee may from time to time and without stockholder approval establish one or more sub-plans under the Plan with respect to one or more Designated Subsidiaries, provided that such sub-plan complies with Section&#160;423 of the Code. </font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:12pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;25.</font><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;">&#160;&#160;&#160;&#160;Withholding</i><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">.&#160;&#160;&#160;&#160;If applicable tax laws impose a tax withholding obligation, each affected employee shall, no later than the date of the event creating the tax liability, make provision satisfactory to the Company for payment of any taxes required by law to be withheld in connection with any transaction related to Options granted to or shares acquired by such employee pursuant to the Plan. The Company may, to the extent permitted by law, deduct any such taxes from any payment of any kind otherwise due to an employee. </font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:12pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;26.</font><i style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:italic;">&#160;&#160;&#160;&#160;Effective Date and Approval of Stockholders</i><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">.&#160;&#160;&#160;&#160;The Amended and Restated 2016 Employee Stock Purchase Plan shall become effective on the date that such amended and restated plan is approved by the Company&#39; stockholders (the &quot;Effective Date&quot;).</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:avoid;width:76.47%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>ptct-20210608.xsd
<DESCRIPTION>EX-101.SCH
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  9.6.7713.40453 -->
<!--Based on XBRL 2.1-->
<!--Created on: 6/9/2021 8:03:16 PM-->
<!--Modified on: 6/9/2021 8:03:16 PM-->
<xsd:schema targetNamespace="http://www.ptcbio.com/20210608" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:srt-types="http://fasb.org/srt-types/2020-01-31" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:currency="http://xbrl.sec.gov/currency/2017-01-31" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:srt-roles="http://fasb.org/srt-roles/2020-01-31" xmlns:country="http://xbrl.sec.gov/country/2017-01-31" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:exch="http://xbrl.sec.gov/exch/2020-01-31" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:us-types="http://fasb.org/us-types/2020-01-31" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:attributeFormDefault="unqualified" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ptct="http://www.ptcbio.com/20210608">
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation" id="DocumentDocumentAndEntityInformation">
        <link:definition>00090 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:type="simple" xlink:href="ptct-20210608_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="ptct-20210608_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>ptct-20210608_lab.xml
<DESCRIPTION>EX-101.LAB
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  9.6.7713.40453 -->
<!--Based on XBRL 2.1-->
<!--Created on: 6/9/2021 8:03:16 PM-->
<!--Modified on: 6/9/2021 8:03:16 PM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink">
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document and Entity Information [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Type</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Period End Date</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity File Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Registrant Name</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Incorporation, State or Country Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Tax Identification Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Address Line One</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, City or Town</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, State or Province</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Postal Zip Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">City Area Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Local Phone Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Written Communications</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Soliciting Material</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Pre-commencement Tender Offer</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Pre-commencement Issuer Tender Offer</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Title of 12(b) Security</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trading Symbol</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Security Exchange Name</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Emerging Growth Company</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Central Index Key</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amendment Flag</label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>ptct-20210608_pre.xml
<DESCRIPTION>EX-101.PRE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  9.6.7713.40453 -->
<!--Based on XBRL 2.1-->
<!--Created on: 6/9/2021 8:03:16 PM-->
<!--Modified on: 6/9/2021 8:03:16 PM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <roleRef xlink:type="simple" xlink:href="ptct-20210608.xsd#DocumentDocumentAndEntityInformation" roleURI="http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation" xmlns="http://www.xbrl.org/2003/linkbase" />
  <presentationLink xlink:role="http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation" xlink:type="extended" xlink:title="00090 - Document - Document and Entity Information" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType_637588657968038570" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_DocumentType_637588657968038570" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate_637588657968038570" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_DocumentPeriodEndDate_637588657968038570" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber_637588657968038570" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityFileNumber_637588657968038570" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName_637588657968038570" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityRegistrantName_637588657968038570" order="4" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode_637588657968038570" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode_637588657968038570" order="5" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber_637588657968038570" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber_637588657968038570" order="6" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1_637588657968038570" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressAddressLine1_637588657968038570" order="7" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown_637588657968038570" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressCityOrTown_637588657968038570" order="8" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince_637588657968038570" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince_637588657968038570" order="9" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode_637588657968038570" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode_637588657968038570" order="10" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode_637588657968038570" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_CityAreaCode_637588657968038570" order="11" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber_637588657968038570" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_LocalPhoneNumber_637588657968038570" order="12" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications_637588657968038570" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_WrittenCommunications_637588657968038570" order="13" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial_637588657968048512" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_SolicitingMaterial_637588657968048512" order="14" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer_637588657968048512" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_PreCommencementTenderOffer_637588657968048512" order="15" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer_637588657968048512" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer_637588657968048512" order="16" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle_637588657968048512" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_Security12bTitle_637588657968048512" order="17" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol_637588657968048512" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_TradingSymbol_637588657968048512" order="18" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName_637588657968048512" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_SecurityExchangeName_637588657968048512" order="19" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany_637588657968048512" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany_637588657968048512" order="20" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey_637588657968048512" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityCentralIndexKey_637588657968048512" order="21" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag_637588657968048512" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_AmendmentFlag_637588657968048512" order="22" use="optional" />
  </presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>ptct-20210608x8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="ptct-20210608.xsd" xlink:type="simple"/>
    <context id="Duration_6_8_2021_To_6_8_2021_WGoHhJpxt0CIR5ZKZpm1Ow">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001070081</identifier>
        </entity>
        <period>
            <startDate>2021-06-08</startDate>
            <endDate>2021-06-08</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="Duration_6_8_2021_To_6_8_2021_WGoHhJpxt0CIR5ZKZpm1Ow"
      id="Tc_oifPGmChQEOsnea0KtYMjw_2_1">0001070081</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="Duration_6_8_2021_To_6_8_2021_WGoHhJpxt0CIR5ZKZpm1Ow"
      id="Tc_xsLViPQZh0mmuSFqXRU-VQ_3_1">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="Duration_6_8_2021_To_6_8_2021_WGoHhJpxt0CIR5ZKZpm1Ow"
      id="Narr_nsEAFxEYWUKmnRkLL7A4Ig">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="Duration_6_8_2021_To_6_8_2021_WGoHhJpxt0CIR5ZKZpm1Ow"
      id="Narr_3vfTKxvI_0mc8vSAinrFFw">2021-06-08</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="Duration_6_8_2021_To_6_8_2021_WGoHhJpxt0CIR5ZKZpm1Ow"
      id="Narr_VIZNz1m2z0S3gn8yp95D4w">PTC THERAPEUTICS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="Duration_6_8_2021_To_6_8_2021_WGoHhJpxt0CIR5ZKZpm1Ow"
      id="Tc_8qGrrFAcJ0KVeNrslwNraw_1_0">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="Duration_6_8_2021_To_6_8_2021_WGoHhJpxt0CIR5ZKZpm1Ow"
      id="Tc__ixgryzHNUiyrISTmGWscg_1_2">001-35969</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="Duration_6_8_2021_To_6_8_2021_WGoHhJpxt0CIR5ZKZpm1Ow"
      id="Tc_1J1XBnmDE0ieSMOdEf1DeQ_1_4">04-3416587</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="Duration_6_8_2021_To_6_8_2021_WGoHhJpxt0CIR5ZKZpm1Ow"
      id="Tc_figXhwMNlEec9Jb20YtT9w_1_0">100 Corporate Court</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="Duration_6_8_2021_To_6_8_2021_WGoHhJpxt0CIR5ZKZpm1Ow"
      id="Narr_gdnIV0_-7kmPUfNty6EqVA">South Plainfield</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="Duration_6_8_2021_To_6_8_2021_WGoHhJpxt0CIR5ZKZpm1Ow"
      id="Narr_sbi59WIQTEyuYDq6Tvj-jg">NJ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="Duration_6_8_2021_To_6_8_2021_WGoHhJpxt0CIR5ZKZpm1Ow"
      id="Tc_YlnLupzWAEqG3GyxKM2D9A_2_2">07080</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="Duration_6_8_2021_To_6_8_2021_WGoHhJpxt0CIR5ZKZpm1Ow"
      id="Narr_O9Vcg13dzkCVbPpM-rSgrA">908</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="Duration_6_8_2021_To_6_8_2021_WGoHhJpxt0CIR5ZKZpm1Ow"
      id="Narr_JXy6NKRf1EqDdnNhtmPjVQ">222-7000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="Duration_6_8_2021_To_6_8_2021_WGoHhJpxt0CIR5ZKZpm1Ow"
      id="Narr_efWfOrgumkOpujZZbD40Tw">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="Duration_6_8_2021_To_6_8_2021_WGoHhJpxt0CIR5ZKZpm1Ow"
      id="Narr_TaqplGfcaU-sSsxwvEDe_Q">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="Duration_6_8_2021_To_6_8_2021_WGoHhJpxt0CIR5ZKZpm1Ow"
      id="Narr_jy6eWaNIm0Cxp9u6g9LEWQ">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="Duration_6_8_2021_To_6_8_2021_WGoHhJpxt0CIR5ZKZpm1Ow"
      id="Narr_nWubzcjC-UiifRhBWY-98w">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="Duration_6_8_2021_To_6_8_2021_WGoHhJpxt0CIR5ZKZpm1Ow"
      id="Tc_86ePEMLuAEuH-yoTf2gJhw_2_0">Common Stock, $0.001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="Duration_6_8_2021_To_6_8_2021_WGoHhJpxt0CIR5ZKZpm1Ow"
      id="Tc_KDYc_RCKLUiyoi_N8uQqyg_2_2">PTCT</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="Duration_6_8_2021_To_6_8_2021_WGoHhJpxt0CIR5ZKZpm1Ow"
      id="Tc_8fQjhQcGhkuzdZs9hSiCVA_2_4">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="Duration_6_8_2021_To_6_8_2021_WGoHhJpxt0CIR5ZKZpm1Ow"
      id="Narr_h2cFllPupUip7JeLmcr54w">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139885051339896">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Jun. 08, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Document and Entity Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun.  08,  2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-35969<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">PTC THERAPEUTICS, INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">04-3416587<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">100 Corporate Court<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">South Plainfield<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">07080<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">908<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">222-7000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.001 par value per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">PTCT<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001070081<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M<B )+LF5&U)=Z7FFMW>3>TFH=>Y!L/?P&HT=S8\?M_P!4$L#!!0    ( -*
MR5(D'INBK0   /@!   :    >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'.U
MD3T.@S ,A:\2Y0 U4*E#!4Q=6"LN$ 7S(Q(2Q:X*MR^% 9 Z=&&RGBU_[\E.
MGV@4=VZ@MO,D1FL&RF3+[.\ I%NTBB[.XS!/:A>LXEF&!KS2O6H0DBBZ0=@S
M9)[NF:*<//Y#='7=:7PX_;(X\ \PO%WHJ45D*4H5&N1,PFBV-L%2XLM,EJ*H
M,AF**I9P6B#BR2!M:59]L$].M.=Y%S?W1:[-XPFNWPQP>'3^ 5!+ P04
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MYHOA/UY_ 5!+ 0(4 Q0    ( -* R5('04UB@0   +$    0
M  "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ TH#)4HX=5"'N
M    *P(  !$              ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L!
M A0#%     @ TH#)4IE<G",0!@  G"<  !,              ( !S $  'AL
M+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " #2@,E25J,7$T$$  !M$
M&               @($-"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L!
M A0#%     @ TH#)4I^@&_"Q @  X@P   T              ( !A P  'AL
M+W-T>6QE<RYX;6Q02P$"% ,4    " #2@,E2EXJ[',     3 @  "P
M        @ %@#P  7W)E;',O+G)E;'-02P$"% ,4    " #2@,E2'#AEZC\!
M   \ @  #P              @ %)$   >&PO=V]R:V)O;VLN>&UL4$L! A0#
M%     @ TH#)4B0>FZ*M    ^ $  !H              ( !M1$  'AL+U]R
M96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ TH#)4F60>9(9 0
MSP,  !,              ( !FA(  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&
2      D "0 ^ @  Y!,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>96</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="ptct-20210608x8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00090 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="ptct-20210608x8k.htm">ptct-20210608x8k.htm</File>
    <File>ptct-20210608.xsd</File>
    <File>ptct-20210608_lab.xml</File>
    <File>ptct-20210608_pre.xml</File>
    <File>ptct-20210608ex10141119a.htm</File>
    <File>ptct-20210608ex31f4f15c6.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "ptct-20210608x8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "ptct-20210608x8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "ptct-20210608_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ptct-20210608_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "ptct-20210608.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2020-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 96,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "ptct",
   "nsuri": "http://www.ptcbio.com/20210608",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ptct-20210608x8k.htm",
      "contextRef": "Duration_6_8_2021_To_6_8_2021_WGoHhJpxt0CIR5ZKZpm1Ow",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00090 - Document - Document and Entity Information",
     "role": "http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ptct-20210608x8k.htm",
      "contextRef": "Duration_6_8_2021_To_6_8_2021_WGoHhJpxt0CIR5ZKZpm1Ow",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Document and Entity Information [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001070081-21-000020-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001070081-21-000020-xbrl.zip
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MT$I&BK9G9D8A7>?P@K8-(B4]CS3SH!'A8-=O7O\M*^ _<: CW0#0\A5K.BE
M;8'3,'20K_;TWPJ)W55"@%!_KAE!I%L'X$,A1K>$8-_7TA2(FF?: #;7IL\Y
M8Q2EASV;!H8$8TCBJ;II@&R 6=6(A+W!>[R4G@V,]*I;@_'3NN$F2"=M,ZF-
M;FZ19J?R(U!$6RI+B!_3QMB]+1-0^ZT0%/ 5E"6!3/@1_+A0N;8T#LD6&!@7
M1(0#TP8" [H'FB;Q5%=YV5I0QU;N8"IO8>P2AFL4;J"N%#XTK0UR@[$&*;<
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M34MF?5.\4Y)X\:K5/VP:W6RS:MOB]3T:S_:>&P&^B6]07>NKZ>0+5J.7[J9
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M<L_6#4_7Z^Y!OL+83]A% KB3@+_^K:#>6VWEWHNE5L:/.ON '=3N)@]_I?I
M>7=H5! [TUT+RH<M:S99/_TV[JA R''I-(%[QM:T/Z.\-I3S Y)#8?O3^'9
M:H@0M/QK#"S&/BN7.^1\7KT$U"5F=W =<;8 .YOC-_.\-3;<63.OJ1VY%20&
M$C^UNR(U"6?&>:JN(6E71<V1F+"@ATT)FRRJ_M%0/R(XH_-@5,)A_U ; %PE
M_MT:;0N]P6M"?6/ZV*?91)72DF+@N-;?HK5F#B6C>%"4?I:Z>RDA:KC5!S9,
MI=@)$,0?BB_K!>REZW5M,!R&%B"VO,_7J&OT.Q$5<*P5?MS2L+($"Z@;FY?U
MH:)+D>D*WF1">%SC<UO1)5*8@.\:+R2.WN?/]P^V1MM;!]M;)^F-"-OQQ4*<
MW&=<IN-8WM1<O+[E.U!23F[X?%N$7GPA\\Y#V%\/T6,M?Q'P8>]NOPEPED=/
MUV0>RZ+&^ZC0KMVA6R6X&B%*0P;C4U6%3N^M=J[0O'-QNI3C+JD+K6O_5%57
M.Q]V+W<'MXB&*W/%WF"5@L?B_-, ?>X+.FTM08-2EZC/S%V]_8+O%/";IG0(
M3DBDFPR#,7_I'@@7#("TQ,%#8)#BBB'[E<[ <B9VY-'*/@_!#9/[%TQM_NI;
MNDK==S'F2R]TB=D"/8+1X[2;>Q"MBXU,.A*3?E_)#J(<H06 <3N^"2PB)5K/
M5@E5DC?BID^$<CJZIBQZ<^F4RZ)6-[HN7?#<^W*F_K@?HU?+E(:-MJ^(/6IT
M3, R\#CO5T58P>$7;Y>FK%@?AHT:"04W8W>;32P(/+>T"SIS[]+Q^*4E#+^[
ME"=R&P49Q#2E[&/8=C7B;[)E!MXXBG@#0N!>^RU&"H;\Q)Q63ZD!N:1/YMVZ
M(E]_QAEVTF<AI#W@J-%BF5Z:%%<9<"8"7I_=>*%/DVO)@BOCTH(@_@5>]V['
M,F]JO&6D3D0^);B[<@-GH\)@*DVT0 \JQY5I/\[#LI#J[8LM774CN?BXWJ2O
MBW+UI[,X.:&+9TH[B\66JJ=O[BG;-T(BQV^XW]2M/'.5"EW."6\P[E09;_^C
MQJ27)MR'VJI>P[2'3>6;3* Z#Q529_YVBI,H&+61=GN(C938Y5K3O>=6G(4X
MW#]X%FQW%U\+]XHFD0VNM0M[JR.2[\21C.8P?HZ9BP.RK%3]/E$49(R%JDWN
M94R@Z8V*301#_GKD YM1KPM\[(WJXA;^F333\O7_ E!+ P04    " #2@,E2
M:J9IR]P&  ">)0  '    '!T8W0M,C R,3 V,#AE>#,Q9C1F,35C-BYH=&WM
M6FU3VS@0_BM[]'J%F?@U+2].R@R$4'(#A GF>O?I1K&56%/%\DERTMROOY5?
M$@@IO4XI4])F)A#+TFIWM<_N(]GM7RRKFR8DC6@,9^'%.<0BRB<TU1!)2C2V
MSIA.(!191E*XH%(RSN%8LGA, 0YLS[5=>W_?L@[;**I3C1%I +O.@>.[O@?N
M?N#ZP9LF7%W ]DW8V2DZG_0[X5]7W7+2JYOC\UX'MBS'>=_L.,Y)>%+>>&V[
M'H22I(II)E+"':=[N05;B=99X#BSV<R>-6TAQTXX<!(]X:\=+H2B=JSCK<.V
M:<&_E,2'[0G5!**$2$7UVZV;\-3:QQZ::4X/VT[]O^P[%/'\L!VS*2@]Y_3M
MUH3(,4LM+;*@Z6:ZA2,=O+W2YZ,U8[%. L]U7[8R$L<L'5N<CG3@>?;>[K)-
MLG&R;!2E<8&DG&@VI4;Z W-/\"*AA83F+E[?FA,'9O6PD4BU-2(3QN?!JP[A
M;"C9J\:K,\JG5+.(X&^%?K44E6STJE5T5^Q?BI)0*&<IK6?Q;.^@I>E';:&4
M,>II6ENE6D'EC>'::4,VH0HNZ0P&8D)2G+)H,5/?FG563C,4/$91W3_/>L>]
M$)JVUW:&Z.=LC:\C3HG$$3IIK;I]G3>?P"D18H;*VBN>GVEPEU^CA!'V%5XJ
MU? +69WN(.R=]CI'81?ZIW!TT;T\P6\(;<?T+9WVY$8_OIUA'\*S+@RZUR&:
M>@(K=O<N._W!57]P%/;ZEZ9AP\R_"CO&_L'15?<F['6N&\9B>Z.,G#+%AHPS
M/0\2%L<T1>F_O=CWW6;K*>S\MDN74$DRFJ->"I<NC6S8U@D%8Y_OMCI"9D(2
MDZR*%J^UTP L4<MFP,)&4I0: TECH!^9TE@^($]C*HNFX1RF3.J<@AB!D9U)
M85PJ4E6WO*,IJL'AUG1P3F;U[6N-%=M<G&"^G!%)&T@!T%C4G:+TB$K-1G,@
M"D:"<S%3P;->ET6*V/P(CIG*.)D'+"T&#;F(/I3 9A@_J2[&E)6SX!$KPR/!
MA0Q>N,6G]54N*B^-V" 5<D+XG;I?-3V4@PR'0OV.EKGOD1=QEC!-+961B :9
MI-8,@6OJ#P(DRJ4T?#@EDP7*;F.)*?@$V$T;0ICA^AC\%4C"!2[AACUN"9D9
M?#%>T^T"F!09N"9R;GHO4+H6LLBWX8+(*(&FUP#OX&"_FORS<TZ$TB"IR?$<
M08[$/ZZ2C:1*5UP>?L]3"OZ;!OBNUWR2^O,3_S_Q?Q__Q]\,_R741TPB'#(B
MR1BQG!C('"& <+,!I_V;07BVP/]#N&*+XEGCB6&C5H ^9PCI.6B!\"+QAA35
M[P8 8,(8ZA^/G#@JTE;&05!D5RTTYO4TGPR1C6$8J 1S<<&[".<0<:)4>:DT
M0@^PQD3)O?*!@[!S0J842*X3+!=E@#"ED-5A+(4S 6?(^"0&TBD;Z;EUBKM:
MN&"<F_';_ILW#42H^>Y4*C201*:J(HLX_S;;N2_FM@1W58(9U1&3"=Z^-LHW
MX%?7=EW/@ .FA*-J&1I==(;M!:%=#KC%:+&8;#/4X*[:]Y0V4UY).J+2J/C_
M9UT94T]L5S\V)@2K8Z#B.,E=7I='2>[WA,/-+T2=;UJ(B&Y EDN5$Q1:U HE
M>%YN"._Q3[/"WEY+P5 0&9L.,1:92 NIS&YR0FF=!<S (A,E@N/^4:TCLX83
MQCE2P0BS4L4$$\ICR#.\FPJ,"VK*&8FPXL7FV+@DK$A6B_&^[]=B3]YUSE$#
M7>6]6A%S*T7"J92AMO>2)\XOZ3\Y,WC&"FHX:(Y%=H8%%:9"E\5T1*9"EO-@
M@EPIQD>FZ)H3[.=,5']B^<FP?/)-L?Q ?"[!1F*1Z3+@#3P6 "[@]SG(KD'C
M_8.@!3Y?W\'G<X;(#[67^TI/]2[A?2^\[%Y?P_NS[J#;/VW<BZ,$HS$BN<(X
M?#"MFHKTV3T0]AEBM4&8+<.ZHK?F-%.,<"#F_2'%S8_)^74N/ZC=K/+U3OX"
MVP_,@AHEL995D-?"G.KHI.V@_,>-Q9@4!S7FJ,2<D_C><\;69N)@,ZW:.CR>
M+XX/\D<1613)F$85FH/B>8.Q9_6.=;>>;QTZRC$GD1^@:\.QR+EYVMUV\D<U
M]^]/?=:5@[5\I7I<?& WF]6S_"\:6!.;YQLSFXJ$2S*AP9H _*+E]7W;]7_,
MN$#&:MZ#":#[D4:Y>7L"_C [OBO<FC%#[PM&VDD8'<$Y'1,._;*2?SGT]O8?
MR<7ENR'EWT36,H8D^C"6 C/72HZZ]>;(W1N5>_T5=[MW#EZJ5W;NG+W<;5N\
MII.1,>HN*?E@D9&F,L!-*XLK._9V[==[+UM#I.U45J^ON(5AY:M'Q;M,A_\!
M4$L#!!0    ( -* R5+S?MFM<QH  %3<   4    <'1C="TR,#(Q,#8P.'@X
M:RYH=&WM/>E3V[ZVW^_,^Q_TN._^2F<2QVMBAY8[:0@T+(&2 "U?,K(M)RY>
M@FR3I'_]DV0[Q-D@$);0=*: ;2U'9]/1T='1E_\.7 ?<(1S8OO?UD\#QGP#R
M#-^TO<[73Q>M_;SZZ;^[_P+D'_L!P)?_S>>!_?/;^3$P?2-RD1<" R,8(A/T
M[;!;!BV_UX,>.$$8VXX#OF';[*"DBL85N5))D#B9EQ4)Y/.[X\U^@P%IQ??*
M26F!$R:+5).N:*%B02N(O"@ M<Q+94$"9R>3Q>-VCFT=0SQ,QUDF#?,C,(I3
M?<25F@C?V08"A[X.ZGMEP$NRAC29STLE ^7EHJCD=0/"?$FV=$&7%<L4Y;&6
MR*\OW9 @ER#8"\HFLK]N=<.P5RX4!CIVN  97,>_*Y /=!!\GA?RDK 5%Q\5
M[??[7%_B?-PI")JF%0:TR:10V;&]FTQ)UC M*_*\5*"?=8+1M/A@JGRF9?IU
M5)0T9(99@)-VE4+\<51T)K"DH%#X>7+<-+K(A7G;"T+H&2-0[$&8)PC(U$P1
M8GL$$D1)4 @Q] ++QRX,"=E(HX*2Y]5[-)5[H1%F&B$O=-OG#-]EG,$7>76L
MS]G(>JA#,2\6[QN9AW!!&FLH+8Z1-9= Q0+Y.HYP>P$M1PC<_=)%T-S]XJ(0
M EH\CVXC^^[KEN%[(9'%?#CL$30G3U^W0C0("S'3%':_A';HH-TOA?1WW);N
MF\/=+Z9]!X)PZ*"O6R[$'=O+AWZO+/&]<(?T6B"?,V5,.^@Y<%CV? _1 O:@
M3%M#./[3-DWDL3])@091$]@V8J@&X3G%REZ$&9+;Q;;:IK1JM_S[OZ\._._=
MP]X@Y*OU<^7ZZ+KG"J?]+>!!E_:-['+-(X,85LD@,73JGHD&1VBX!6SSZU;+
M:/NV=7;@5KL_:J>!AR!_%/XZ^=UOBVUA:Y<GO,F7>%X5OA0R\+TDN!6B*$VJ
M+/<=V!F!.0B.+^VS']==WG6CYO[MS_.+_.6/MD3!M* 3H"D("UGD$A9"F"AL
M%.Q^H0)<#IC $9 !$^ARE[$@E9-\*A#<(#"WDL^46[YN!;;;<RAO%;)MQ-V-
M]\$> S_"[(EQ;3E!$QO3D]"4-H082=,GVZ3/EHTP8 "AF=JB6C_*4G2R\F[Z
M*MMZCZ#3-],G(EPXW",3RRZ%,\\7B9I)Z]U_&X%ISBF:?DF?TTX*&42E6!VA
ML3 F.U-RYL)!OF^;9&(5>/X_.SUHTKDY[R K)&\X2;E_A^U.]_ZE']B4$J0C
MAY#DC@GI6+N&@R NZW[8W9GL8E;-7EK/(H/(6]"UG6'Y4\MV40 :J _.?1=Z
MGW+Q&_([($.W/NVPTH']!Y&FB2))(27=AKY;%L9>465#GRF&\M"Q.U[9("1#
M>$?W,4'-J Y'&@*![]@F^#?/_J4EF+Z:\3E69^5$DP74.!D?# -/)!_94Q\Q
M+.J^8R851SW3,G=V8.NV0S@I$4/2Y#__5D5>VOE2H$T3$O96A:YI7#QF* KY
M^'3((9/CMF"(NBH0F24_^+9LBD9;MS38EG2S*$*QB(JF114&?*VQZM,#%4JS
MB+:U>]&HMVI[H-FJM&K-+P7][4FB/8LD[P[!S5KUXKS>JM>:H-+8 [6?U>^5
MQD$-5$]/3NK-9OVTL<%ZW/UR2,]B^:K2_%YO'+1.&SFPQU4Y(/**K&TPF_#E
M<U"[?WI^\L^_A2*_P]#Y<F;?7K)$;C&KG&K6!L2X[06UROZ@]NOJXLCUSF^.
MCTL5N=YY &@U?Q03?](D_,N9X:G*39BMW(AJ.Z\U6N"\=G9ZWMJ(V^HQ?!;A
M(()>"$(?-)%!Y2L61D$"/@:"LFU^CE_X%@B[B!:*,+%)"<"U@=&%7@>!BA$"
M\EG0)'E#HV=#WN_:(<J3[P8J]S#*]S'LD1IT-4.Q?(YZ/@[!=OI,E@X.H48(
MT!WU_V'V&9F?RP"DHUJU3HV],E^W[$%8-@D8+FFQ:\+AD,""O%DZ]XRMOFKQ
MFFQ,^4IW5NMH<%=O\ZZAWC4KMH?W]_NS65B;S<&'D8> F@,4XHU.?N($_=*^
MH7/4L0/JT0L;Y,L8 US6KQM_!%?\PS>ECJ<.>YJR)T\SP(32:E5!ZWOMO')6
MNVC5J\T<J#>JW(;X3[)[MVL#2/0WI0M5)U7?)=T/ 0Q LX<,ZK<Q@>V!:A<2
MM8(_KSE&DR6UHLAR">EF6X6&U)952VQKHB"WH:CRDJ[23U*RI(:I@] 19/[(
MJAP(-]'O//9.+WXVOE]7VF*;GRSY^_A0P[R%?M;<DO+=K_OHPK_Y04J*DR6Q
M>-1VPR.A>W&E':"CZU_UJSN#EI0G2YK%/?5:]X)3_G9X)$GG]=.:T>BWI>G>
M+[Y?72'IAZ7S^4/]Z,+5[>OZ@#HRIWJO-4Z'U^8OB&I(M^QNX_CD_(],VTQ[
M#Z'NH)0$B6?'\!T']@)43O\8)VN14*(;RRKU9"6N[Y1>S%$&H]!/7\1>,O8F
MXTP;]T_%91B_4&CR#ASZ45)IS%-&( YQ"FH"@A#S46BF[^\0#FT#.@G7Q?R3
MM"()7$GYSS@+)A#0OX%$_O/Q_PGGW5A?/FG?<OQ^RH'I,YO"RSI&\";?)UA\
MT"&8,#8#(BT*]<!WHA!-#'HUHO@8P1,>+V6QYS3Y&9J/)8'(O*6S*;#!^DMA
MG3)^<</X&\;_V["^8?P7)$$AQ'1&?I'9]W7,SQ=<-=. "[J9&:(>]N_H8BF[
M;(X7377/\#%9S;.^FK1TU8^\$ ^KOHE&^];J[0'&^Q7CD#^Z1 T<./T&AOVV
MP S#QR^C]PA?]LGR?>XJ:H7J;"7+F@RQ8A?5],]E(5]*):PG&TYRV;[M(-*Z
MCO"(I=KVH(.'?[XW+NPAKC=;[L%58'0(2XE+L11/PZ@4K:AM>.HOXZD6'-23
MJ ^#-3?!8,*A\/.;Y^[5>!LU3T[-FB7LH1^$P>3E&$S.2[)05-328@Y[UW/1
M8UPT3/E3?_QIV$48'$;8#DR;>>O?G1P]VKIXGB/GW0K@8^A9]5W7#H(-^=:3
M?/7S)JBY/<<?(OQQM(QO@8S%^7G#F^O'F]2: _%LNZ'?&M(O:S:!AL]]GM P
M!>8&?]L]F"4< V^]5;3<OI#!FZ8BZL1"5:'2EDU3;^NR -M&42LAM21#WDI#
M+4>[*&W%"H]:9^B4'S9_2X>#4H#:QLQ](=C\:8?*U?Z@YE;-'C[MG \O?W=F
M[>'<:I;H%GFW= -_1LV.W%*O[.[X'LYZ[,RHJ]B8D55.D39NNK?U3VMS*;#!
M^DMAG3*^N&'\=^&?7DH)?0PG3L4T,0J"Y->Q[2%AY,"Q[,[/;O^DX=20H1WJ
M(O\K;&G+.YT)RX!JLN) Y*\(AZOQ%2Y65^_75[B4R+^U:?5,"WTC@8^4P"KY
M\Q2W_+XW%CC7,;WZ)=_.EV[<LPNK$0Z+M=O+RE+2UR366A><.=#V+!LYYDS1
M>WQS.?#" ?P9I#"7Z"D^P_Z=S4XSCS 3Z+:B7=5_M&K#Z-?>;;%U]SO_>SJ@
M?]%0&H=KH8;>WWKZ'>JO5^+',S\(H7-M]S*;L[\<[SCJ_;FJU&X/I(/AX.A$
MW-,J223@$AL=)5[E5[K'\;K:]#%.U02/- ;U#!.1MGO0 ;4!,B)JCH)3R[(-
M%#S!J;41PC>G+1$+0.7B/?JREG 2O3686[OW<?04/*&T$X 0.:C7]3T$/.;V
MS0$B/$Y$Z0T@6> 1E6>B\N@LR..5SO8+3^?4K*D0 .\5)IN^3[5+HR-(YI^;
MZJ5^UCO)XV8'+V?8:#0-P+-LF<\O;<L<^T1XSRC9QK?&&0(.?PZ+C:-S2ZC=
M[IE>HQNZ9[\O?RR% %$4\R6>GS]EO#4GO^\C$0L/GS3\$,!>SR':E^BNS7FW
MQ\T ^SXF[)><,L$@>4SF?**R+'K Q.L@$S2I.0^.81 F1]W6_<C)ZO!K>W1W
MJ"P5)RV.:A<9-^QX)N%,[/>P3?TINC\ .G+\/D4O_4BQ'OLEU/P1L CH9(ZP
M S)AA(@T;=)#H('M1DX(/>1'@3,$ =%R@35DU9,*OD[P%V]/)6="\6A6 A%I
M!P-Z@"CY9OD.@8#6HZ&.-HUY",#V%SN+9?IWV28&M&V0X02()MO9!0?(0YA8
M@76/M!ZQ<!=0X40N'M7G\M_.&/>0S^6,#.!IGJ@X.59>=WSC)E.?UDG,9H$K
MOLSZ:3(,5O=]1X>$24+"K^-3Y!6V0\*7-%8F\I(-T6!LGD36E76*.Y%[<]J+
M?E]?ZWLRW^I/#-GP'1^7T^PS&40W4<='X*(.FD.7Z/9)B1MC3(^"[&0FVN35
M&-O0[3%&9ZTDR_=TGIQ\X]>+;+QDW 35XP,'O;&3VN>1@V)!ED4ED;F)P]GT
M3/:V4 +5_7,@2CQ'"GY^3[;L1FQ>2&R:/E&BA >\S@F9!,A,X(S)3 O>]IP#
MRX 7^: 9#/IWM3W4_K'^,G,_:. FHYXC,((,\X(X)C.9+ 8CB9%Y+BZY$9J_
M06C.,*+S#,VLQU+$4',(GUI69F'V>UA$5[!1=_GJH*=%Q8YV7+OZ ,)#!I\W
MQD;_N)E'D,V\N*TGV4$>)4]QA8U$_84250^"".'9<N5=1?H?XW<U?V';UGGW
MV]6OO*9^ $/NB7(EH;R\;2PA5TF%C5S-V9Q?Z,X9,YGC92S"9"'<FYL6Z5[E
M)0M<0H[R!_ ")0&0)=72D*R);4U1A+9L&D9;-Q6QC30)J0;494,L3@8KXBLA
M_!6<*,:-6U7$&Z\UV#LQTF"03,F?S=_??EV>.JU:7CNH-0=];/-WZ<&R3$GM
MIB:VY>,PX ^&->'ZHOKMNW/13TX(O;\ R)4FHBAQFK:)MGO%:+NQA%N>S])M
MI7N'O+HAQ&N'/0K:AO\W_/]7$B+5_ZJ\0?N;A?HF\^]$JO/>8'XF\Y<(+WW.
M%F6+7BD1YX8TNL!P8!",+-15:(1YJ&%7=O1H#LCPI='S>&3,#\U="B/C4],Z
MLP:&+#(D7BIOTWBJ#6,\GS$2G;W&C)'F?V0J Z6^!M\#A.3DS?W:.(N>9^G6
M^)Z)5T32G-7UN!,M7^+$*39ZN3B@Q/TP%$2=:>W[M#Y%=%8[.8XJM>A[?NBW
M++%SV.TGIPH7>9VHUXV0K1GZQDT._!_/\;P B.R!.^A$"/3H'2Y=ENAGCF-K
M1;K@KPJYS$X,[X6O7XN)DTDEGE-&''RT]\MHGU>/CB_LH6^W&VKTXW;826*?
M%_I-6]76ACM7><H],SO]'=PYN5%!I[3I1&NI^DV=Z_?9J:D*MG[\[OXP#KHW
MT1_S.M"Z3;MZ64F2\RYBX 8,3'@+#AQ?APYH(@<9(3B!^ :%#_+U7QD7/66X
MU3V3;I,@H ^!P8+;R.<;8HL@E@!I(NC,#@ 9 2*H[%#;MH/]?MBENRUI)FL3
M6;87Y[$>"YWA%3!]J<']7082V*8%2SLL?"8M3/HBK-*CJ;!I(./8OHVHY\49
M#<ZZ)6'4,MV^N:\WUC:WYML)KZM%MW9K<XC_"E<@+-X'C0\)I> =,.B2'.MC
M6Z!=T=AWG+.H=V'W2H?HV#6P(D]N@2ZSZ?GP_N7?S5[3&L=:H$/HF8J9"LF>
M"H#M$G7#%#Y1-Y[/-A"C +%2!$])F"U=#C/'&HBO):3LQ/IRAK1S>G<OBZ'U
MR%#(%XP(6D@]HL2@9]#8)F@8-!4H+4PO(S4A-H,XP-9<N'LI;</L[N6X=N+
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MB,BC:BD0Z:8.+2'-ZK/Q5[^!OWK11#"5_&KA76BD"4@S?JSX/K/YX)Q-)$_
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M2P$"% ,4    " #2@,E26?EX@G4%  !\/   %0              @ &' P
M<'1C="TR,#(Q,#8P.%]L86(N>&UL4$L! A0#%     @ TH#)4@ 1<'QT!
M?28  !4              ( !+PD  '!T8W0M,C R,3 V,#A?<')E+GAM;%!+
M 0(4 Q0    ( -* R5+\BW>)#Q\   VQ   <              "  =8-  !P
M=&-T+3(P,C$P-C X97@Q,#$T,3$Q.6$N:'1M4$L! A0#%     @ TH#)4FJF
M:<O<!@  GB4  !P              ( !'RT  '!T8W0M,C R,3 V,#AE>#,Q
M9C1F,35C-BYH=&U02P$"% ,4    " #2@,E2\W[9K7,:  !4W   %
M        @ $U-   <'1C="TR,#(Q,#8P.'@X:RYH=&U02P4&      8 !@";
) 0  VDX

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
